UK, Denmark set up payment models for Hemgenix hemophilia B gene therapy 02-Jul-2024 By Jonathan Smith Hot on the heels of last year’s EU approval of Hemgenix, the first gene therapy for the blood disorder hemophilia B, the UK and Denmark are the latest European nations to take steps to pay for the treatment.
